Table of Contents

NOMLong SqueezeHigh Condition IntensityFailed

NOM Price Rise Analysis - March 28, 2026

NOM's price has risen significantly, accompanied by negative funding rates. Historical data suggests that this scenario could potentially lead to a price drop if long positions take profit. We are monitoring for potential price movements.

March 28, 2026 at 05:00 PM

Key Metrics

Current Price

$0.003

Funding Rate

-5.4609%

24h Avg FR

-5.4609%

FR Trend

decreasing

Open Interest

$2.61M

Est. Liquidation Price

$0.003

Take Profit

$0.0025

-15%

Stop Loss

$0.0041

+45%

Max Leverage (No Liq.)

2x

100% ÷ 45% = 2x

Tradeable Exchanges

Analysis

NOM has experienced a significant price increase of 54.61% in the last 24 hours, while the average daily funding rate is -5.461%, indicating that short positions are paying long positions. The falling funding rate trend suggests increasing pressure on shorts. Open interest currently stands at $2.61 million.

In previous instances where similar negative funding rates coincided with price increases, profit-taking by long positions has occasionally resulted in downward price corrections. These corrections often occur as long holders sell their assets, increasing selling pressure.

NOM is available for trading on Bybit, MEXC, and Aster. Current funding rates on these exchanges are: Bybit: -12.000%, MEXC: -3.164%, and Aster: -1.218%. The highly negative funding rate on Bybit may amplify any potential price movements.

Levels to monitor for potential support are around the $0.00 level. Levels to monitor for potential resistance are around the $0.00 level. If the funding rate trend reverses and becomes positive, or if the price fails to hold at observed support levels, this scenario may be invalidated.

NTRN is exhibiting similar market conditions, with a daily funding rate of -5.348% and a falling trend. This indicates that the observed dynamics are not isolated to NOM. It is critical to remember that this is educational research.

*Disclaimer: This is an educational research report, not financial advice. Past performance does not guarantee future results.*

Risk Assessment

A significant risk to this scenario is a sudden influx of new capital into NOM, which could maintain or increase the price despite the negative funding rates. Market sentiment, driven by news or social media trends, can also override technical indicators.

Volatility is inherently high in cryptocurrency markets, and NOM, with its relatively low market capitalization, is likely subject to significant price swings. Low liquidity could further amplify these price movements, making it difficult to execute large trades without impacting the market price.

*Disclaimer: This is an educational research report, not financial advice. Past performance does not guarantee future results. Trading cryptocurrencies involves substantial risk of loss.*

Trading Strategy

Theoretically, delta-neutral strategies could be explored, but they are complex and require advanced understanding of derivatives and risk management. With NOM currently priced around $0.00, a trader might hypothetically consider strategies around observed support levels around $0.00 (approximately 15-20% above the current price) and resistance levels around $0.00.

It is crucial to remember that any such strategy carries substantial risk and is purely for educational purposes. Individual traders must conduct thorough due diligence, consider their risk tolerance, and consult with a qualified financial advisor before making any trading decisions.

*Disclaimer: This is NOT a trading recommendation. Individual traders must do their own research and risk management.*

Exchange Data

ExchangePriceFunding RateOpen Interest
Bybit$0.003-2.0000%-
MEXC$0.003-1.0548%-
Aster$0.003-0.4061%-

Disclaimer: This analysis is for informational purposes only and should not be considered as financial advice. Cryptocurrency trading involves substantial risk and may not be suitable for all investors. Past performance is not indicative of future results. Always do your own research before making investment decisions.